---
document_datetime: 2025-04-09 12:00:32
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/besremi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: besremi-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.6949036
conversion_datetime: 2025-12-27 10:00:52.063585
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Besremi

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0039/G            | This was an application for a group of variations. B.II.z - Quality change - Finished product - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 29/03/2025                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                |            |     |             |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|
| II/0037   | B.IV.1.c - Change of a measuring or administration device - Addition or replacement of a device which is an integrated part of the primary packaging                                                                                                                                                                                                                                                                                                        | 19/12/2024 | n/a |             |
| IA/0038   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                               | 11/10/2024 | n/a |             |
| IB/0036   | B.I.c.z - Container closure system of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                              | 31/07/2024 | n/a |             |
| II/0033/G | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation B.IV.1.c - Change of a measuring or administration device - Addition or replacement of a device which is an integrated part of the primary packaging B.IV.1.c - Change of a measuring or administration device - Addition or replacement of a device which is an integrated part of the primary packaging | 27/06/2024 |     | SmPC and PL |
| IB/0035/G | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure                                                                                                                                                                                                                                                                                                       | 24/06/2024 | n/a |             |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | (including replacement or addition) B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |             |                                                                                                                                                                                                                                |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0034/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits | 20/06/2024 | n/a        |             |                                                                                                                                                                                                                                |
| R/0031    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 12/10/2023 | 07/12/2023 | SmPC and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Besremi in the approved indication remains favourable and therefore recommended the renewal of the marketing |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                |            |            |             | authorisation with unlimited validity.   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------|
| PSUSA/10756 /202302 | Periodic Safety Update EU Single assessment - ropeginterferon alfa-2b                                                                                                                                                                                                                          | 28/09/2023 | n/a        |             | PRAC Recommendation - maintenance        |
| II/0026             | B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method                         | 19/01/2023 | n/a        |             |                                          |
| IB/0029             | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                            | 06/12/2022 | 07/12/2023 | SmPC        |                                          |
| II/0025             | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required | 01/12/2022 | n/a        |             |                                          |
| IB/0027             | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer                                                                                 | 23/11/2022 | n/a        |             |                                          |
| II/0021             | Update of sections 4.8, 5.1 and 5.2 of the SmPC based on results from CONTINUATION-PV study. An                                                                                                                                                                                                | 17/11/2022 | 07/12/2023 | SmPC and PL | Not applicable.                          |

<div style=\"page-break-after: always\"></div>

|                     | open-label, multicentre, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with polycythaemia vera who previously participated in the PROUDPV Study. The Package Leaflet is updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |     |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0028             | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                          | 26/10/2022 | n/a |                                   |
| PSUSA/10756 /202202 | Periodic Safety Update EU Single assessment - ropeginterferon alfa-2b                                                                                                                                                                                                                                                                                                                          | 29/09/2022 | n/a | PRAC Recommendation - maintenance |
| IA/0024             | B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                                                                                                                                                                                                                      | 11/05/2022 | n/a |                                   |
| IB/0022             | B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits                                                                                                                                                                                                                                                                    | 19/04/2022 | n/a |                                   |
| IB/0020             | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                            | 20/01/2022 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0019           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                             | 01/10/2021   | 31/01/2022   | Annex II and PL        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-----------------------------------|
| PSUSA/10756 /202102 | Periodic Safety Update EU Single assessment - ropeginterferon alfa-2b                                                                                                                                                                                                                                                                              | 30/09/2021   | n/a          |                        | PRAC Recommendation - maintenance |
| IAIN/0018/G         | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                           | 20/09/2021   | 31/01/2022   | SmPC, Labelling and PL |                                   |
| IB/0017             | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                               | 13/09/2021   | n/a          |                        |                                   |
| IB/0016/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS A.7 - Administrative change - Deletion of manufacturing sites B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS | 16/07/2021   | n/a          |                        |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0013             | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                        | 08/06/2021   | n/a        |                        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------|
| IA/0014             | B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised                                                                                        | 27/04/2021   | n/a        |                        |                                   |
| PSUSA/10756 /202008 | Periodic Safety Update EU Single assessment - ropeginterferon alfa-2b                                                                                                                                                                                                                                                      | 11/03/2021   | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0011             | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes                                                                                                                        | 13/01/2021   | 31/01/2022 | SmPC, Labelling and PL |                                   |
| IB/0012             | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                       | 18/12/2020   | n/a        |                        |                                   |
| IA/0009/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 31/10/2020   | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10756 /202002   | Periodic Safety Update EU Single assessment - ropeginterferon alfa-2b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 01/10/2020   | n/a   | PRAC Recommendation - maintenance   |
|-----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------------|
| IA/0008               | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 01/09/2020   | n/a   |                                     |
| II/0006/G             | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method | 25/06/2020   | n/a   |                                     |
| IB/0005               | B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/03/2020   | n/a   |                                     |
| PSUSA/10756 /201908   | Periodic Safety Update EU Single assessment - ropeginterferon alfa-2b                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 12/03/2020   | n/a   | PRAC Recommendation - maintenance   |

<div style=\"page-break-after: always\"></div>

| IA/0004   | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                                                                                                                                                                                                                 | 07/02/2020   | n/a        |           |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------|
| N/0002    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                           | 18/12/2019   | 31/01/2022 | Labelling |
| IB/0001/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 08/07/2019   | n/a        |           |